Skip to main content

CORRECTION

Pathol. Oncol. Res., 31 January 2023
Volume 29 - 2023 | https://doi.org/10.3389/pore.2023.1610954

Corrigendum: Systemic treatment of breast cancer. 1st Central-Eastern European professional Consensus Statement on breast cancer

Gbor Rubovszky &#x;Gábor Rubovszky1*†Judit Kocsis&#x;Judit Kocsis2†Katalin BorKatalin Boér3Nataliya ChilingirovaNataliya Chilingirova4Magdolna DankMagdolna Dank5Zsuzsanna KahnZsuzsanna Kahán6Dilyara KaidarovaDilyara Kaidarova7Erika KvrErika Kövér8Bibiana Vertkov Krakovsk,Bibiana Vertáková Krakovská9,10Kroly MhrKároly Máhr11Bela Mri&#x;kov,Bela Mriňáková9,10Bla PikBéla Pikó12Ivana Boovi&#x;-Spasojevi&#x;Ivana Božović-Spasojević13Zsolt HorvthZsolt Horváth2 on behalf of the Central-Eastern European Academy of Oncology (CEEAO) International Professional Panel‡
  • 1Department of Clinical Pharmacology, National Institute of Oncology, Chest and Abdominal Tumours Chemotherapy “B”, Budapest, Hungary
  • 2Center of Oncoradiology, Bács-Kiskun County Teaching Hospital, Kecskemét, Hungary
  • 3Department of Oncology, Szent Margit Hospital, Budapest, Hungary
  • 4Clinic Center of Excellence, Heart and Brain Hospital, Science and Research Institute, Medical University-Pleven, Pleven, Bulgaria
  • 5Oncology Centre, Semmelweis University, Budapest, Hungary
  • 6Oncotherapy Clinic, University of Szeged, Szeged, Hungary
  • 7Kazakh Institute of Oncology and Radiology, Almaty, Kazakhstan
  • 8Institute of Oncotherapy, Faculty of Medicine, University of Pécs, Pécs, Hungary
  • 91st Department of Oncology, Faculty of Medicine, Comenius University, Bratislava, Slovakia
  • 10Medical Oncology Department, St. Elisabeth Cancer Institute, Bratislava, Slovakia
  • 11Department of Oncology, Szent Rafael Hospital of Zala County, Zalaegerszeg, Hungary
  • 12County Oncology Centre, Pándy Kálmán Hospital of Békés County Council, Gyula, Hungary
  • 13Institute for Oncology and Radiology of Serbia, Daily Chemotherapy Hospital, Belgrade, Serbia

A Corrigendum on
Systemic treatment of breast cancer. 1st Central-Eastern European professional consensus statement on breast cancer

by Rubovszky G, Kocsis J, Boér K, Chilingirova N, Dank M, Kahán Z, Kaidarova D, Kövér E, Krakovská BV, Máhr K, Mriňáková B, Pikó B, Božović-Spasojević I and Horváth Z (2022). Pathol. Oncol. Res. 28:1610383. doi: 10.3389/pore.2022.1610383

In the original article, the reference for 118 was incorrectly written as:

“Johnston SRD, Hegg R, Im SA, Park IH, Burdaeva O, Kurteva G, et al. Phase III, Randomized Study of Dual Human Epidermal Growth Factor Receptor 2 (HER2) Blockade With Lapatinib Plus Trastuzumab in Combination With an Aromatase Inhibitor in Postmenopausal Women With HER2-Positive, Hormone Receptor-Positive Metastatic Breast Cancer: ALTERNATIVE. Journal of clinical oncology: official journal of the American Society of Clinical Oncology. 2018;36(8):741-8.”

It should be

“Johnston SRD, Hegg R, Im SA, Park IH, Burdaeva O, Kurteva G, et al. Phase III, Randomized Study of Dual Human Epidermal Growth Factor Receptor 2 (HER2) Blockade With Lapatinib Plus Trastuzumab in Combination With an Aromatase Inhibitor in Postmenopausal Women With HER2-Positive, Hormone Receptor-Positive Metastatic Breast Cancer: Updated Results of ALTERNATIVE. J Clin Oncol. 2021;39(1):79–89. doi: 10.1200/JCO.20.01894.”

The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.

Keywords: early breast cancer, locally advanced breast cancer, adjuvant treatment, neoadjuvant treatment, metastatic breast cancer, inflammatory breast cancer, guideline

Citation: Rubovszky G, Kocsis J, Boér K, Chilingirova N, Dank M, Kahán Z, Kaidarova D, Kövér E, Krakovská BV, Máhr K, Mriňáková B, Pikó B, Božović-Spasojević I and Horváth Z (2023) Corrigendum: Systemic treatment of breast cancer. 1st Central-Eastern European professional Consensus Statement on breast cancer. Pathol. Oncol. Res. 29:1610954. doi: 10.3389/pore.2023.1610954

Received: 18 November 2022; Accepted: 19 January 2023;
Published: 31 January 2023.

Edited by:

Andrea Ladányi, National Institute of Oncology (NIO), Hungary

Copyright © 2023 Rubovszky, Kocsis, Boér, Chilingirova, Dank, Kahán, Kaidarova, Kövér, Krakovská, Máhr, Mriňáková, Pikó, Božović-Spasojević and Horváth. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

*Correspondence: Gábor Rubovszky, cnVib3Zzemt5Z0BnbWFpbC5jb20=

†These authors have contributed equally to this work and share first authorship

‡Panel members are listed in the Supplementary Appendix

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.